Takaomi Saido Selected Research

Takaomi Saido Research Topics

Disease

23	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 12/2010
2	Amyloid Plaque 06/2023 - 01/2018
2	Wounds and Injuries (Trauma) 06/2023 - 05/2007
2	Gliosis 01/2023 - 12/2017
2	Inflammation (Inflammations) 01/2022 - 01/2020
2	Cognitive Dysfunction 01/2020 - 01/2016
2	Necrosis 01/2020 - 08/2002
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2019 - 01/2018
2	Dementia (Dementias) 12/2017 - 06/2012
1	Disease Progression 01/2024
1	Neuroinflammatory Diseases 01/2024
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2022
1	Memory Disorders (Memory Loss) 12/2019
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 12/2018
1	Amyloid angiopathy 12/2018
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 12/2018
1	Intellectual Disability (Idiocy) 10/2018
1	Iron Deficiencies 01/2018
1	Amyloidosis 12/2017
1	Multiple System Atrophy 12/2013
1	Hyperglycemia 12/2012
1	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2012
1	Acute Coronary Syndrome 11/2012
1	Thrombosis (Thrombus) 11/2012
1	Myocardial Infarction 11/2012
1	Fatigue 11/2005
1	Ototoxicity 09/2004
1	Cicatrix (Scar) 09/2004
1	Ganglion Cysts (Ganglion) 09/2004
1	Neoplasms (Cancer) 08/2002
1	Brain Neoplasms (Brain Tumor) 08/2002
1	Glioma (Gliomas) 08/2002

Drug/Important Bio-Agent (IBA)

14	Amyloid (Amyloid Fibrils)IBA 01/2024 - 12/2010
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2012
6	Amyloid beta-PeptidesIBA 01/2023 - 01/2018
5	Peptides (Polypeptides)IBA 01/2020 - 06/2012
4	CalpainIBA 12/2013 - 09/2004
2	HMGB1 Protein (HMG1)IBA 10/2021 - 01/2016
2	CalciumIBA 09/2015 - 05/2007
1	InflammasomesIBA 01/2024
1	CaspasesIBA 01/2024
1	Amino Acids FDA Link 01/2020
1	Myristoylated Alanine-Rich C Kinase SubstrateIBA 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	ProteomeIBA 12/2019
1	PrionsIBA 12/2018
1	Growth Hormone (Somatotropin)IBA 12/2018
1	tau Proteins (tau Protein)IBA 12/2018
1	polyglutamine-binding protein 1IBA 10/2018
1	IronIBA 01/2018
1	Transforming Growth Factor-beta Type II ReceptorIBA 12/2017
1	Monoclonal AntibodiesIBA 01/2016
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 02/2014
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 12/2013
1	Dopamine and cAMP-Regulated Phosphoprotein 32IBA 12/2013
1	SynucleinsIBA 12/2013
1	CalbindinsIBA 12/2013
1	SpectrinIBA 12/2013
1	NF-E2 Transcription FactorIBA 12/2012
1	Streptozocin (Streptozotocin)FDA Link 12/2012
1	calpastatinIBA 12/2012
1	calpain inhibitorsIBA 12/2012
1	Indicators and Reagents (Reagents)IBA 11/2012
1	EnzymesIBA 11/2012
1	Biomarkers (Surrogate Marker)IBA 11/2012
1	Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA 06/2012
1	fodrinIBA 05/2007
1	Free RadicalsIBA 05/2007
1	Therapeutic UsesIBA 05/2007
1	Cytochromes c (Cytochrome c)IBA 05/2007
1	Neprilysin (Neutral Endopeptidase)IBA 11/2005
1	Caspase 3 (Caspase-3)IBA 09/2004
1	Amikacin (A.M.K)FDA LinkGeneric 09/2004
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 08/2002
1	Matrix Metalloproteinases (MMPs)IBA 08/2002
1	Metalloproteases (Metalloproteinases)IBA 08/2002
1	Tissue Inhibitor of Metalloproteinase-1IBA 08/2002
1	Tissue Inhibitor of Metalloproteinase-2IBA 08/2002

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2020
1	Operative Surgical Procedures 12/2018
1	Subcutaneous Injections 01/2016